Developments in T Cell Based Cancer Immunotherapies

This volume illustrates the salient aspects of cancer biology relevant to the successful implementation of immunotherapy. Topics include enhancement of antigen-specific immune responses by anti-cancer vaccines, modulation of the function of T cells within the tumor microenvironment, and the effects...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Ascierto, Paolo A. (Επιμελητής έκδοσης), Stroncek, David F. (Επιμελητής έκδοσης), Wang, Ena (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Humana Press, 2015.
Έκδοση:1st ed. 2015.
Σειρά:Cancer Drug Discovery and Development,
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03836nam a22005415i 4500
001 978-3-319-21167-1
003 DE-He213
005 20151201032050.0
007 cr nn 008mamaa
008 151126s2015 gw | s |||| 0|eng d
020 |a 9783319211671  |9 978-3-319-21167-1 
024 7 |a 10.1007/978-3-319-21167-1  |2 doi 
040 |d GrThAP 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
082 0 4 |a 614.5999  |2 23 
245 1 0 |a Developments in T Cell Based Cancer Immunotherapies  |h [electronic resource] /  |c edited by Paolo A. Ascierto, David F. Stroncek, Ena Wang. 
250 |a 1st ed. 2015. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Humana Press,  |c 2015. 
300 |a XV, 305 p. 26 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Cancer Drug Discovery and Development,  |x 2196-9906 
505 0 |a 1 New insight of peptide vaccination in cancer immunotherapy -- 2 The determinants of T cell function for effective anticancer vaccine -- 3 T cell fate in the tumor microenvironment -- 4 T cell receptor avidity and affinity and tumor specific TCR engineer -- 5 Host genetic variation and somatic alteration associated with favorable or compromised T cell function -- 6 Production of Clinical T Cell Therapies -- 7 Clinical success of adoptive cell transfer therapy using tumor infiltrating lymphocytes.-8 Harnessing stem cell-like memory T cells for adoptive cell transfer therapy of cancer -- 9 T cell blockade- anti-CTLA4 immunotherapy against cancer and Abscopal effect in combination therapy -- 10 T cell modulation- anti-OD-1 antibodies for the treatment of cancer -- 11 T cell based therapies in combination with other procedures -- 12 Chimeric antigen receptor T cells CD19 CAR -- 13 Hematopoietic Stem Cell transplantation as immune therapy of malignancies. 
520 |a This volume illustrates the salient aspects of cancer biology relevant to the successful implementation of immunotherapy. Topics include enhancement of antigen-specific immune responses by anti-cancer vaccines, modulation of the function of T cells within the tumor microenvironment, and the effects of genetic, epigenetic, developmental, and environmental determinants on T cell function. Other topics covered include the ex vivo expansion of T or other immune cells and their genetic modification or reprogramming to increase their ability to survive and expand when adoptively transferred back to the patients. Specific attention is devoted to the genetic manipulation of T cells through the introduction of re-directed T cell receptors, chimeric antibody receptors, and other genetic manipulation aimed at improving their effectiveness as anti-cancer agents. Furthermore, the revolutionary role of checkpoint inhibitors and their potential in combination with other immunotherapeutic approaches or with standard chemo and radiation therapy are extensively discussed. 
650 0 |a Medicine. 
650 0 |a Cancer research. 
650 0 |a Immunology. 
650 0 |a Molecular biology. 
650 0 |a Cell biology. 
650 1 4 |a Biomedicine. 
650 2 4 |a Cancer Research. 
650 2 4 |a Immunology. 
650 2 4 |a Molecular Medicine. 
650 2 4 |a Cell Biology. 
700 1 |a Ascierto, Paolo A.  |e editor. 
700 1 |a Stroncek, David F.  |e editor. 
700 1 |a Wang, Ena.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319211664 
830 0 |a Cancer Drug Discovery and Development,  |x 2196-9906 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-21167-1  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)